Navigation Links
PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit
Date:4/2/2008

Strategic Acquisition Creates Expanded Biodefense Pipeline

ANNAPOLIS, Md., April 2, 2008 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: PIP) a biodefense company specializing in the development and commercialization of medical countermeasures against biological and chemical threats, announced today that it has completed its acquisition of Avecia's biodefense vaccines business previously announced on March 20, 2008.

David P. Wright, President and Chief Executive Officer, commented, "PharmAthene's mission is to become a leading provider of biodefense medical countermeasures that are needed by the U.S. government and its allies. We have advanced this mission by pursuing an acquisitive growth strategy focused on high priority, next generation biodefense products for which the government has expressed a clear need and an intent to procure. The acquisition of Avecia's biodefense vaccines addresses both of these aspects and adds important near-term value creation milestones to our calendar. With the addition of Avecia's vaccines, PharmAthene now has established an extensive biodefense portfolio targeting U.S. government requirements."

PharmAthene's biodefense portfolio now includes:

-- A recombinant Protective Antigen (rPA) anthrax vaccine

-- A recombinant dual antigen Plague vaccine manufactured in E coli

-- A third generation rPA anthrax vaccine program

-- Valortim(TM), a fully human monoclonal antibody being co-developed with

Medarex for the prevention and treatment of anthrax infection

-- Protexia(R) a novel bioscavenger to prevent and treat organophosphate

nerve agent poisoning

Under the agreement, PharmAthene has acquired all of the assets related
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. PharmAthene Reports Year-End 2007 Financial Results
2. Department of Defense Awards $5.8 Million Contract Modification Providing Additional Funding for PharmAthenes Protexia(R) Program
3. PharmAthene Year-End 2007 Earnings Conference Call and Webcast Scheduled for Monday, March 31, 2008
4. PharmAthene to Delay Release of Full Year 2007 Financial Results
5. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
6. PharmAthene to Present at the Cowen and Company 28th Annual Health Care Conference
7. PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008
8. PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations
9. PharmAthene to Present at the BIO CEO & Investor Conference 2008
10. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
11. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013   Oligomerix, Inc. , ... disease modifying therapeutics for Alzheimer,s disease (AD) and ... its Series B financing, which includes both issuance ... would represent approximately $2.8M in new investments in ... supported the raise. Funding from ...
(Date:5/22/2013)... May 22, 2013  Cleveland BioLabs, Inc. (NASDAQ: CBLI) today ... Second Annual Marcum LLP Microcap Conference, May 30, in ... Neil Lyons , CPA, Chief Financial Officer of ... on May 30 at 1:30 p.m. Eastern Time.  A live ... on the Investors page of the Cleveland BioLabs website at ...
(Date:5/22/2013)... Envera announced today that Michael McErlean has ... has an extensive background in cell production and served ... , Mike Matheny, President and Owner of ... join our team”. “Mike’s background is perfectly suited to ... and downstream processing equipment”, added Matheny. “Mike’s hands on ...
(Date:5/21/2013)... WEST PALM BEACH, Fla. , May 21, ... Inc. (NYSE: FCN ), the global ... and enhance their enterprise value (the "Company"), announced ... sciences focused personnel that were formerly included within ... Forensic and Litigation Consulting segment to form a ...
Breaking Biology Technology:Oligomerix, Inc. Completes Series B Financing 2Oligomerix, Inc. Completes Series B Financing 3Cleveland BioLabs to Present at Second Annual Marcum LLP Microcap Conference 2Envera Appoints Michael McErlean Fermentation Manager 2FTI Consulting Releases Realigned Segment Information Reflecting Newly Combined Health Solutions Practice 2
... ... detection, diagnostics capabilities , ... Argonne, IL (PRWEB) September 3, 2009 -- Researchers at the ... improve the stability of antibodies. The technique could lead to better biosensors, disease ...
... , , FREMONT, Calif., Sept. ... leading developer of state-of-the-art gene expression, genotyping, cell biology and ... President and Chief Executive Officer, will deliver a corporate presentation ... conference will be held September 9-11, 2009, at the New ...
... YORK, Sept. 3 Reportlinker.com announces that a new market research ... Smart Glass: Technologies and Global Markets , ... This report: , , , ... , Describes various smart glass technologies including ...
Cached Biology Technology:Argonne Researchers Develop Method that Aims to Stabilize Antibodies 2Argonne Researchers Develop Method that Aims to Stabilize Antibodies 3Argonne Researchers Develop Method that Aims to Stabilize Antibodies 4WaferGen to Present at the Rodman and Renshaw Annual Global Investment Conference 2WaferGen to Present at the Rodman and Renshaw Annual Global Investment Conference 3Reportlinker Adds Smart Glass: Technologies and Global Markets Report 2Reportlinker Adds Smart Glass: Technologies and Global Markets Report 3
(Date:5/21/2013)... "patient monitoring" device attached to a whale entangled in ... fishing lines changed a whale,s diving and swimming behavior. ... to eat and migrate, depletes their energy as they ... in a slow death. , The scientists in this ... to a two-year-old female North Atlantic right whale called ...
(Date:5/21/2013)... at USC have found that a class of pharmaceuticals ... , The drugs, known as "TSPO ligands," are ... looked at the effects of TSPO ligand in young ... and in aged mice when pathology was quite severe," ... School of Gerontology. "TSPO ligand reduced measures of pathology ...
(Date:5/21/2013)... health stores, phosphatidylserine is a natural food supplement ... improve cognition and slow memory loss, it,s a ... Now a team headed by Prof. Gil Ast ... Department of Human Molecular Genetics have ... of genes involved in degenerative brain disorders, including ...
Breaking Biology News(10 mins):Study reveals how fishing gear can cause slow death of whales 2Study reveals how fishing gear can cause slow death of whales 3Drugs found to both prevent and treat Alzheimer's disease in mice 2Common food supplement fights degenerative brain disorders 2
... is available in German . For ... Institute for Demographic Research in Rostock (MPIDR) has calculated a ... capita CO2 emissions. This profile applies to U.S. citizens, as ... model developed for the analysis is universally valid, and can ...
... to travel large distances to survive climate change, international ... Ocean, the Western and Eastern Pacific and the subarctic ... to escape extinction, according to a new study by ... Science . "Our research shows that species ...
... Nose, which has the potential to diagnose tuberculosis (TB) ... Grand Challenges Canada and the Bill & Melinda Gates ... this ground-breaking technology. The funding will ... detect TB immediately and non-invasively from the patient,s breath, ...
Cached Biology News:Individual CO2 emissions decline in old age 2Individual CO2 emissions decline in old age 3Individual CO2 emissions decline in old age 4Sea life 'must swim faster to survive' 2Sea life 'must swim faster to survive' 3Creating an 'electronic nose' to sniff out tuberculosis from a patient's breath 2
Anti-NCAPD3 Monoclonal AntibodyOther Sub-Family: not assigned-Other Applications: Immunoprecipitation, Western Blot...
... BIP-NC H-IPMIK-OH Lyophilized solid. ... LIGHT. HYGROSCOPIC. PACKAGED UNDER INERT GAS. A ... V5 (Cat. No. 196810) that serves as ... apoptosis (~200 μM). Purity: ≥97% by ...
BD Falcon microtest assay plate. 1536 well 12l, black, flat-bottom PS. Polystyrene, nonsterile, no lid. (15/sp, 60/ca) Packaging: 15 / pack, 60 / case ...
... flexible, fully automated microplate strip washer for 96- ... automated microplate strip washing capability, the Columbus combines ... operation. , Features ... 8, 12 or 16 channels, crosswise aspiration, overflow ...
Biology Products: